162 related articles for article (PubMed ID: 12860499)
1. The effect of anemia treatment on selected health-related quality-of-life domains: a systematic review.
Ross SD; Fahrbach K; Frame D; Scheye R; Connelly JE; Glaspy J
Clin Ther; 2003 Jun; 25(6):1786-805. PubMed ID: 12860499
[TBL] [Abstract][Full Text] [Related]
2. Dialysis patients treated with Epoetin alfa show improved anemia symptoms: A new analysis of the Canadian Erythropoietin Study Group trial.
Keown PA; Churchill DN; Poulin-Costello M; Lei L; Gantotti S; Agodoa I; Gitlin M; Gandra SR; Mayne TJ
Hemodial Int; 2010 Apr; 14(2):168-73. PubMed ID: 20345390
[TBL] [Abstract][Full Text] [Related]
3. Association of anemia correction with health related quality of life in patients not on dialysis.
Alexander M; Kewalramani R; Agodoa I; Globe D
Curr Med Res Opin; 2007 Dec; 23(12):2997-3008. PubMed ID: 17958944
[TBL] [Abstract][Full Text] [Related]
4. Mortality risk of darbepoetin alfa versus epoetin alfa in patients with CKD: systematic review and meta-analysis.
Wilhelm-Leen ER; Winkelmayer WC
Am J Kidney Dis; 2015 Jul; 66(1):69-74. PubMed ID: 25636816
[TBL] [Abstract][Full Text] [Related]
5. Erythropoiesis-stimulating agents in the treatment of anemia in myelodysplastic syndromes: a meta-analysis.
Moyo V; Lefebvre P; Duh MS; Yektashenas B; Mundle S
Ann Hematol; 2008 Jul; 87(7):527-36. PubMed ID: 18351340
[TBL] [Abstract][Full Text] [Related]
6. Assessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfa.
Patrick DL; Gagnon DD; Zagari MJ; Mathijs R; Sweetenham J;
Eur J Cancer; 2003 Feb; 39(3):335-45. PubMed ID: 12565986
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.
Case DC; Bukowski RM; Carey RW; Fishkin EH; Henry DH; Jacobson RJ; Jones SE; Keller AM; Kugler JW; Nichols CR
J Natl Cancer Inst; 1993 May; 85(10):801-6. PubMed ID: 8487324
[TBL] [Abstract][Full Text] [Related]
8. Does epoetin alfa improve health-related quality of life in chronically ill patients with anemia? Summary of trials of cancer, HIV/AIDS, and chronic kidney disease.
Kimel M; Leidy NK; Mannix S; Dixon J
Value Health; 2008; 11(1):57-75. PubMed ID: 18237361
[TBL] [Abstract][Full Text] [Related]
9. The effect of a change in epoetin alfa reimbursement policy on anemia outcomes in hemodialysis patients.
Berns JS; Fishbane S; Elzein H; Lynn RI; Deoreo PB; Tharpe DL; Meisels IS
Hemodial Int; 2005 Jul; 9(3):255-63. PubMed ID: 16191075
[TBL] [Abstract][Full Text] [Related]
10. Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review of the literature.
Ross SD; Allen IE; Henry DH; Seaman C; Sercus B; Goodnough LT
Clin Ther; 2006 Jun; 28(6):801-31. PubMed ID: 16860166
[TBL] [Abstract][Full Text] [Related]
11. Epoetin alfa improves quality of life in patients with cancer: results of metaanalysis.
Jones M; Schenkel B; Just J; Fallowfield L
Cancer; 2004 Oct; 101(8):1720-32. PubMed ID: 15386341
[TBL] [Abstract][Full Text] [Related]
12. Dose efficiency of erythropoiesis-stimulating agents for the treatment of patients with chemotherapy-induced anemia: a systematic review.
Forbes CA; Worthy G; Harker J; Kleijnen J; Kutikova L; Zelek L; Van Belle S
Clin Ther; 2014 Apr; 36(4):594-610. PubMed ID: 24656152
[TBL] [Abstract][Full Text] [Related]
13. Once-weekly epoetin alfa for treating the anemia of chronic kidney disease.
Provenzano R; Garcia-Mayol L; Suchinda P; Von Hartitzsch B; Woollen SB; Zabaneh R; Fink JC;
Clin Nephrol; 2004 Jun; 61(6):392-405. PubMed ID: 15224803
[TBL] [Abstract][Full Text] [Related]
14. Impact of epoetin alfa on clinical end points in patients with chronic renal failure: a meta-analysis.
Jones M; Ibels L; Schenkel B; Zagari M
Kidney Int; 2004 Mar; 65(3):757-67. PubMed ID: 14871396
[TBL] [Abstract][Full Text] [Related]
15. Epoetin alfa in cancer patients: evidence-based guidelines.
Turner R; Anglin P; Burkes R; Couture F; Evans W; Goss G; Grimshaw R; Melosky B; Paterson A; Quirt I;
J Pain Symptom Manage; 2001 Nov; 22(5):954-65. PubMed ID: 11728799
[TBL] [Abstract][Full Text] [Related]
16. Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy.
Quirt I; Robeson C; Lau CY; Kovacs M; Burdette-Radoux S; Dolan S; Tang SC; McKenzie M; Couture F;
J Clin Oncol; 2001 Nov; 19(21):4126-34. PubMed ID: 11689580
[TBL] [Abstract][Full Text] [Related]
17. Impact of Epoetin-beta on anemia and health-related quality of life in cancer patients: a prospective observational study using the generic 15D instrument.
Mäenpää J; Puistola U; Riska H; Sintonen H; Saarni O; Juvonen E; Kellokumpu-Lehtinen PL
Anticancer Res; 2014 May; 34(5):2325-9. PubMed ID: 24778039
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin in cancer-related anemia. Review of clinical evidence.
Crawford J
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):41-53. PubMed ID: 12380954
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Pennington S; Vale L; Wallace S; MacLeod A
Cochrane Database Syst Rev; 2001; (4):CD003266. PubMed ID: 11687180
[TBL] [Abstract][Full Text] [Related]
20. Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population.
Cella D; Zagari MJ; Vandoros C; Gagnon DD; Hurtz HJ; Nortier JW
J Clin Oncol; 2003 Jan; 21(2):366-73. PubMed ID: 12525531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]